Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV908
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,958
Award facts
- Contract value 100% obligated
- $21,957.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,957.68 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on January 29, 2026, with an ultimate completion date of January 30, 2026. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's broader relationship with the Defense Logistics Agency's Medical Supply Chain, which includes a substantial Indefinite Delivery Contract valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the AmerisourceBergen name), serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. This specific award for Zepbound reflects the company's role in supporting military healthcare programs with specialty medications, including diabetes and weight management treatments, consistent with its established track record fulfilling federal medical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FV908?
SPE2DR26FV908 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV908 worth?
The government has obligated $21,958 on SPE2DR26FV908.
Is contract SPE2DR26FV908 an order under another contract?
Yes. SPE2DR26FV908 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV908 competed?
The extent of competition for SPE2DR26FV908 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award